United States · Funded startup

Who invested in OncoFusion Therapeutics

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 15 Nov 2026

$525Kraised across 1 round since 2013, from 1 source

Latest round
Debt, $525KMar 2013
Investors
0
See who backed them

The rounds

  1. Mar 2013
    Debt$525K

    No investor was named in the report.

    Reported by sec.govSEC filing: $525K sold, first sale Feb 2013

Funding filed with regulators

OncoFusion Therapeutics filed one raise, $525K in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Feb 2013$525K9 investorsdebtof $750K offeredSEC Form D

Founders and team

From the SEC filings it signed: 2 on the team.

  • Peter SugarExecutive Officeri
  • Shaomeng WangExecutive Officer, Directori

On the board, as filediMel Sorensen

Quick answers about OncoFusion Therapeutics

How much has OncoFusion Therapeutics raised?

OncoFusion Therapeutics has raised $525K across 1 round since 2013.

When did OncoFusion Therapeutics last raise?

OncoFusion Therapeutics's most recent round was a Debt of $525K in Mar 2013.

What was OncoFusion Therapeutics's biggest round?

Its most recent round, $525K in Mar 2013, is also its largest on record.

What stage is OncoFusion Therapeutics at?

OncoFusion Therapeutics's latest named round is a Debt, in Mar 2013.

Where is OncoFusion Therapeutics based?

OncoFusion Therapeutics is based in the United States.

Companies like OncoFusion Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.